TCL Archive Congress Passes Biomedical Research Authorization, Regular Appropriations Bill; NCI Gets $1.183 Billion October 19, 1984
TCL Archive UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says September 24, 1999
TCL Archive Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting. April 1, 2005
TCL Archive NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive” June 11, 2010
TCL Archive Conversation with The Cancer Letter: McKinsey Charge: Create Plan To Expand MD Anderson’s Reach February 7, 2014
